- Home
- Publications
- Publication Search
- Publication Details
Title
Programmed cell death, redox imbalance, and cancer therapeutics
Authors
Keywords
-
Journal
APOPTOSIS
Volume 26, Issue 7-8, Pages 385-414
Publisher
Springer Science and Business Media LLC
Online
2021-07-08
DOI
10.1007/s10495-021-01682-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- APR-246 induces early cell death by ferroptosis in acute myeloid leukemia.
- (2021) Rudy Birsen et al. HAEMATOLOGICA
- APR-246 combined with 3-deazaneplanocin�A, panobinostat or temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells
- (2021) Javier De La Rosa et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Down-regulation of Autophagy-Associated Protein Increased Acquired Radio-Resistance Bladder Cancer Cells Sensitivity to Taxol
- (2021) Xiangli Ma et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Palbociclib renders human papilloma virus-negative head and neck squamous cell carcinoma vulnerable to the senolytic agent navitoclax
- (2021) Nicholas J. Gadsden et al. MOLECULAR CANCER RESEARCH
- Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome
- (2021) Wu‐tong Ju et al. Cancer Communications
- Sorafenib Induces Apoptosis and Inhibits NF-κB-mediated Anti-apoptotic and Metastatic Potential in Osteosarcoma Cells
- (2021) CHING-HSUAN WU et al. ANTICANCER RESEARCH
- Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(−) breast cancer receiving salvage treatment with everolimus/exemestane
- (2021) Maria Spiliotaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder
- (2021) Amarnath Challapalli et al. Clinical Genitourinary Cancer
- A phase I dose-escalation trial of radiation therapy and concurrent cisplatin for stage II and III triple-negative breast cancer
- (2021) Jennifer R. Bellon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Delivery systems for vorinostat in cancer treatment: An updated review
- (2021) Vu Khanh Hoa Le et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
- (2021) Christoph Röllig et al. LEUKEMIA
- Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two‐Cohort , Phase Ib/ II Trial
- (2021) Jie Xu et al. ONCOLOGIST
- Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
- (2021) Vinod A. Pullarkat et al. Cancer Discovery
- Bardoxolone-Methyl (CDDO-Me) Impairs Tumor Growth and Induces Radiosensitization of Oral Squamous Cell Carcinoma Cells
- (2021) Cornelius Hermann et al. Frontiers in Pharmacology
- Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells
- (2021) Michèle J. Hoffmann et al. Genes
- Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
- (2021) Sascha D. Markowitsch et al. Cancers
- A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
- (2021) Chui-ying Chan et al. Frontiers in Oncology
- Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma
- (2021) Yu Tian et al. Translational Lung Cancer Research
- Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT‐3 and RADIANT‐4 trials
- (2021) Nicola Fazio et al. CANCER
- Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer
- (2021) Arlene E. Garcia‐Soto et al. CANCER
- A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma
- (2021) Simon Chowdhury et al. Clinical Genitourinary Cancer
- Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study
- (2021) Michael Szarek et al. Clinical Genitourinary Cancer
- Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial
- (2021) Raghav Sundar et al. GUT
- Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute
- (2021) Keisuke Kidoguchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Wheat Germ Agglutinin-Conjugated Disulfide Cross-Linked Alginate Nanoparticles as a Docetaxel Carrier for Colon Cancer Therapy
- (2021) Hock Ing Chiu et al. International Journal of Nanomedicine
- Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
- (2021) Jonathan E. Rosenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non–small cell lung cancer
- (2021) Yasuto Yoneshima et al. Journal of Thoracic Oncology
- Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial
- (2021) Xing Lv et al. LANCET ONCOLOGY
- Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling
- (2021) Jing Cui et al. MOLECULAR MEDICINE
- Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor‐Tyrosine Kinase Inhibitor Therapies
- (2021) Andrew J. Wiele et al. ONCOLOGIST
- lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma
- (2021) Hideharu Yamada et al. Oncology Letters
- Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
- (2021) Hanne-Line Rabben et al. Frontiers in Pharmacology
- Acceptability and feasibility of S-1 plus cisplatin adjuvant chemotherapy for completely resected non-small cell lung cancer: an open-label, single arm, multicenter, phase 2 trial
- (2021) Shugo Uematsu et al. Journal of Thoracic Disease
- Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer
- (2021) Claire Falandry et al. JAMA Oncology
- Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer
- (2021) Zongliang Lu et al. Frontiers in Oncology
- Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study
- (2021) Krittiya Korphaisarn et al. Frontiers in Oncology
- Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
- (2021) Fausto Castagnetti et al. Frontiers in Oncology
- Drug-Loaded, Polyurethane Coated Nitinol Stents for the Controlled Release of Docetaxel for the Treatment of Oesophageal Cancer
- (2021) Paris Fouladian et al. Pharmaceuticals
- Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival
- (2021) Agnieszka Maj-Hes et al. ADVANCES IN THERAPY
- Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis
- (2021) Fanyong Qu et al. Cancer Cell International
- Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer
- (2021) Chia-Yi Lin et al. CANCER LETTERS
- Trilostane, a 3β-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib
- (2021) Jiunn-Chang Lin et al. INVESTIGATIONAL NEW DRUGS
- HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
- (2021) Beige Zong et al. ONCOLOGY REPORTS
- Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer
- (2020) Danielle M. Valcourt et al. ACS Nano
- Ferroptosis Suppressor Protein 1 (FSP1) and Coenzyme Q10 Cooperatively Suppress Ferroptosis
- (2020) Kamyar Hadian BIOCHEMISTRY
- Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
- (2020) Steve Boudewijns et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
- (2020) Yanwei Su et al. CANCER LETTERS
- AMG-176, an Mcl-1 antagonist, shows preclinical efficacy in chronic lymphocytic leukemia
- (2020) Xue Yi et al. CLINICAL CANCER RESEARCH
- A Phase I study of Everolimus and Bendamustine in Patients with relapsed/refractory lymphoid hematologic malignancies
- (2020) Rasmus T. Hoeg et al. Clinical Lymphoma Myeloma & Leukemia
- Copper sulfate-induced endoplasmic reticulum stress promotes hepatic apoptosis by activating CHOP, JNK and caspase-12 signaling pathways
- (2020) Hongbin Wu et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma
- (2020) Didier Decaudin et al. EUROPEAN JOURNAL OF CANCER
- Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)
- (2020) Fay H. Cafferty et al. EUROPEAN JOURNAL OF CANCER
- Curcumin Affects HSP60 Folding Activity and Levels in Neuroblastoma Cells
- (2020) Celeste Caruso Bavisotto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor‐B cell acute lymphoblastic leukemia
- (2020) Shannon R. Sweeney et al. MOLECULAR CARCINOGENESIS
- Novel Fluorescent Mitochondria-Targeted Probe MitoCLox Reports Lipid Peroxidation in Response to Oxidative Stress In Vivo
- (2020) Konstantin G. Lyamzaev et al. Oxidative Medicine and Cellular Longevity
- The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death
- (2020) I-Lun Hsin et al. Cancers
- Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
- (2020) Namrata Khurana et al. Antioxidants
- Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway
- (2020) Jingjing Zhang et al. ANTI-CANCER DRUGS
- Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis
- (2020) Chengkui Yang et al. APOPTOSIS
- The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds
- (2020) Fabrizio Fontana et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin
- (2020) Robert Jones et al. BJU INTERNATIONAL
- MEK inhibition overcomes everolimus resistance in gastric cancer
- (2020) Hongfang Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Lipid peroxidation and ferroptosis: The role of GSH and GPx4
- (2020) Fulvio Ursini et al. FREE RADICAL BIOLOGY AND MEDICINE
- Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial
- (2020) Kazuyuki Shimada et al. LANCET ONCOLOGY
- Effect of shikonin on the proliferation and apoptosis of human ovarian cancer cell SKOV3
- (2020) Dan-feng Zhang et al. MEDICINE
- Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer
- (2020) Farong Zang et al. MOLECULAR MEDICINE
- A New Hybrid δ-Lactone Induces Apoptosis and Potentiates Anticancer Activity of Taxol in HL-60 Human Leukemia Cells
- (2020) Katarzyna Gach-Janczak et al. MOLECULES
- Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds
- (2020) Jie Yu et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial
- (2020) Tatul Saghatelyan et al. PHYTOMEDICINE
- Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib
- (2020) Romane Florent et al. Cell Death & Disease
- Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells
- (2020) Qing Tang et al. Drug Design Development and Therapy
- CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer
- (2020) Michael S. Ball et al. Scientific Reports
- Transferrin Receptor Is a Specific Ferroptosis Marker
- (2020) Huizhong Feng et al. Cell Reports
- Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma
- (2020) Hanjie Yi et al. Cancer Medicine
- Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment
- (2020) Lucia Nogova et al. Cancer Medicine
- Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated Glioblastoma
- (2020) R.F. Barajas et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma
- (2020) BENDIKT KRAMER et al. ANTICANCER RESEARCH
- LncRNA HOTAIR contributes Taxol-resistance of hepatocellular carcinoma cells via activating AKT phosphorylation by down-regulating miR-34a
- (2020) Yunfei Duan et al. BIOSCIENCE REPORTS
- Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3)
- (2020) Yukinori Kurokawa et al. Gastric Cancer
- International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
- (2020) Sheela Rao et al. JOURNAL OF CLINICAL ONCOLOGY
- Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial
- (2020) Fabian Knörr et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
- (2020) Erica H. Bell et al. JOURNAL OF CLINICAL ONCOLOGY
- Function and Regulation of Noncanonical Caspase-4/5/11 Inflammasome
- (2020) Sampsa Matikainen et al. JOURNAL OF IMMUNOLOGY
- Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2
- (2020) Yoshihito Morimoto et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer
- (2020) Zsófia Küronya et al. PATHOLOGY & ONCOLOGY RESEARCH
- Shikonin is a novel and selective IMPDH2 inhibitor that target triple‐negative breast cancer
- (2020) Wanyan Wang et al. PHYTOTHERAPY RESEARCH
- Emerging Mechanisms and Disease Relevance of Ferroptosis
- (2020) Brent R. Stockwell et al. TRENDS IN CELL BIOLOGY
- MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
- (2020) Nabanita Mukherjee et al. Cell Death & Disease
- Raltitrexed versus 5‐fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial
- (2020) Pengwei Yan et al. Cancer Medicine
- Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights
- (2020) Giulia Chiabotto et al. Cancers
- An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer Cells
- (2020) Anie P. Masilamani et al. Cancers
- Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer
- (2020) Zekun Liu et al. iScience
- XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent way
- (2020) Ruili Huang et al. Cancer Cell International
- Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial)
- (2020) Satoshi Sai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma
- (2020) Filip Janku et al. CLINICAL CANCER RESEARCH
- Quality of Life Impact of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma
- (2020) Pierluigi Porcu et al. Clinical Lymphoma Myeloma & Leukemia
- Perioperative Treatment in Muscle-invasive Bladder Cancer: Analysis of Secondary Endpoints in a Randomized Trial Comparing Gemcitabine and Cisplatin Versus Dose-dense Methotrexate, Vinblastine, Adriamycin, and Cisplatin
- (2020) Irbaz Bin Riaz et al. EUROPEAN UROLOGY
- Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
- (2020) Dong Woo Kang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
- (2020) Zachary Miklja et al. JOURNAL OF CLINICAL INVESTIGATION
- Overexpression of NDRG2 promotes the therapeutic effect of pazopanib on ovarian cancer
- (2020) Ying Cui et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple Negative Breast Cancer
- (2020) Yuan Yuan et al. ONCOLOGIST
- A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma
- (2020) Qiuyun Luo et al. ONCOLOGY RESEARCH
- Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma
- (2020) Minchen Liu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation
- (2020) Shaimaa Abdel-Ghany et al. 3 Biotech
- Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer
- (2020) Srikala S. Sridhar et al. JAMA Oncology
- The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model
- (2020) Diana Spiegelberg et al. Frontiers in Oncology
- Π electron-stabilized polymeric micelles potentiate docetaxel therapy in advanced-stage gastrointestinal cancer
- (2020) Chenghua Liang et al. BIOMATERIALS
- Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four Trial
- (2020) Sarah Brown et al. Clinical Lymphoma Myeloma & Leukemia
- Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
- (2020) Yuzhu Hu et al. International Journal of Nanomedicine
- Application of Taxol Nanomicelles with Lyp-1 Target in Targeted Therapy of Colon Cancer
- (2020) Xinian Wen et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study
- (2020) Sven de Vos et al. LEUKEMIA & LYMPHOMA
- Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line
- (2020) Wei Yang et al. LIFE SCIENCES
- A G-Quadruplex-Binding Small Molecule and the HDAC Inhibitor SAHA (Vorinostat) Act Synergistically in Gemcitabine-Sensitive and Resistant Pancreatic Cancer Cells
- (2020) Ahmed Abdullah Ahmed et al. MOLECULES
- Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer
- (2020) Thomas S. C. Ng et al. RADIOLOGY
- Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway‐related proteins
- (2020) Marium M. Shamaa FEBS Open Bio
- BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance
- (2020) María Josefina Quezada et al. Cancers
- Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
- (2020) Xiang Song et al. Frontiers in Oncology
- Melatonin Can Modulate the Effect of Navitoclax (ABT-737) in HL-60 Cells
- (2020) Alexey Lomovsky et al. Antioxidants
- Long-term outcomes of concomitant cisplatin plus radiotherapy versus radiotherapy alone in patients with stage IIIB squamous cervical cancer: A randomized controlled trial
- (2020) Ana Maria Dias Fachini et al. GYNECOLOGIC ONCOLOGY
- Anti-tumor effect of sulfasalazine in neuroblastoma
- (2019) Marie R. Mooney et al. BIOCHEMICAL PHARMACOLOGY
- Desmoid tumours stalled by sorafenib
- (2019) Katharine H. Wrighton Nature Reviews Clinical Oncology
- Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors
- (2019) Xin Yu et al. PLoS One
- Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies
- (2019) Fiona H Tan et al. OncoTargets and Therapy
- A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma
- (2019) Mengjiao Wu et al. EBioMedicine
- mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
- (2019) Dorota Ciołczyk-Wierzbicka et al. Journal of Cell Communication and Signaling
- Combination treatment with BRAFV600E inhibitor, vemurafenib, and BH3 mimetic, navitoclax, for BRAF mutant thyroid carcinoma
- (2019) Ju Hye Jeong et al. THYROID
- Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma
- (2019) Binu K. Sasi et al. LEUKEMIA
- Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma
- (2019) Shannon M. Matulis et al. LEUKEMIA
- Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial
- (2019) Yun Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Sulfasalazine may modulate the CD 44v9‐ xCT system and enhance CDDP ‐induced cytotoxic effects in metastatic bladder cancer
- (2019) Koichiro Ogihara et al. CANCER SCIENCE
- Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
- (2019) Cheng-cheng Zhang et al. APOPTOSIS
- Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)
- (2019) Torsten Kessler et al. ANNALS OF HEMATOLOGY
- Lipid metabolism in cancer cells under metabolic stress
- (2019) Rimsha Munir et al. BRITISH JOURNAL OF CANCER
- Venetoclax is an option in B‐cell prolymphocytic leukaemia following progression on B‐cell receptor pathway inhibitors
- (2019) Nikila Patil et al. BRITISH JOURNAL OF HAEMATOLOGY
- Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial
- (2019) Lynne M Howells et al. JOURNAL OF NUTRITION
- Ponatinib Inhibits Proliferation and Induces Apoptosis of Liver Cancer Cells, but Its Efficacy Is Compromised by Its Activation on PDK1/Akt/mTOR Signaling
- (2019) Chang Liu et al. MOLECULES
- Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma
- (2019) Kyle A. Davis et al. PEDIATRICS
- Endoplasmic Reticulum Stress Is Involved in Stress-Induced Hypothalamic Neuronal Injury in Rats via the PERK-ATF4-CHOP and IRE1-ASK1-JNK Pathways
- (2019) Shanyong Yi et al. Frontiers in Cellular Neuroscience
- Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial
- (2019) Giorgio V Scagliotti et al. Lancet Respiratory Medicine
- Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
- (2019) Rachna T. Shroff et al. JAMA Oncology
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma
- (2019) Stephen E. Spurgeon et al. BRITISH JOURNAL OF HAEMATOLOGY
- The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer
- (2019) Sandro Pignata et al. GYNECOLOGIC ONCOLOGY
- Venetoclax for Refractory Myeloid Sarcoma
- (2019) Abraham S. Kanate et al. Journal of Oncology Practice
- α-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway
- (2019) Lianqiao Qiao et al. FASEB JOURNAL
- Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis
- (2019) Natalia Siwecka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)
- (2019) Anne S. Tsao et al. JOURNAL OF CLINICAL ONCOLOGY
- Fenretinide via NOXA induction, enhanced activity of the BCL-2 inhibitor venetoclax in high BCL-2-expressing neuroblastoma preclinical models
- (2019) Thinh H. Nguyen et al. MOLECULAR CANCER THERAPEUTICS
- Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer
- (2019) Daniel J. George et al. PROSTATE
- Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer
- (2019) Daniel J. George et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The synergistic effect between hydrogen peroxide and nitrite, two long-lived molecular species from cold atmospheric plasma, triggers tumor cells to induce their own cell death
- (2019) Georg Bauer Redox Biology
- Recent Progress in Ferroptosis Inducers for Cancer Therapy
- (2019) Chen Liang et al. ADVANCED MATERIALS
- Ivermectin augments the in vitro and in vivo efficacy of cisplatin in epithelial ovarian cancer by suppressing Akt/mTOR signaling
- (2019) Xiaohong Zhang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines
- (2019) Rebecca S.S. Barbosa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- FSP1 is a glutathione-independent ferroptosis suppressor
- (2019) Sebastian Doll et al. NATURE
- The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
- (2019) Kirill Bersuker et al. NATURE
- Ginger extract activates caspase independent paraptosis in cancer cells via ER stress, mitochondrial dysfunction, AIF translocation and DNA damage
- (2019) Divya Nedungadi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- The Xc− inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism
- (2019) Zijie Zheng et al. CELLULAR ONCOLOGY
- Dynamics of Singlet Oxygen-Triggered, RONS-Based Apoptosis Induction after Treatment of Tumor Cells with Cold Atmospheric Plasma or Plasma-Activated Medium
- (2019) Georg Bauer et al. Scientific Reports
- Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
- (2019) Teresa Di Desidero et al. Frontiers in Oncology
- Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells
- (2019) Jingjing Liu et al. BIOSCIENCE REPORTS
- Aurora A Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes with Navitoclax to Induce Rhabdomyosarcoma Cell Death
- (2019) Johannes Ommer et al. CANCER RESEARCH
- A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
- (2019) Cristina P. Rodriguez et al. CLINICAL CANCER RESEARCH
- Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
- (2019) Ryan L. Steinberg et al. JOURNAL OF UROLOGY
- GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues
- (2018) Matilde Maiorino et al. ANTIOXIDANTS & REDOX SIGNALING
- Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies
- (2018) Ali Razaghi et al. APOPTOSIS
- Aspirin restores ABT-737-mediated apoptosis in human renal carcinoma cells
- (2018) Yen-Chuan Ou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Efficacy and safety of everolimus in patients younger than 12 months with congenital subependymal giant cell astrocytoma
- (2018) Ichiro Kuki et al. BRAIN & DEVELOPMENT
- Venetoclax as a single agent and in combination with PI3K-MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma
- (2018) Huijuan Jiang et al. BRITISH JOURNAL OF HAEMATOLOGY
- MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment
- (2018) Kyle Crassini et al. BRITISH JOURNAL OF HAEMATOLOGY
- CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer
- (2018) Eun Hye Kim et al. CANCER LETTERS
- Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
- (2018) Glenn J. Hanna et al. CLINICAL CANCER RESEARCH
- Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial
- (2018) Yu-Ning Wong et al. Clinical Genitourinary Cancer
- A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
- (2018) Victor Yazbeck et al. Clinical Lymphoma Myeloma & Leukemia
- MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin
- (2018) Katja Seipel et al. HAEMATOLOGICA
- A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma
- (2018) Yi Xia et al. International Journal of Clinical Oncology
- Apoptosis, Paraptosis and Autophagy: Death and Survival Pathways Associated with Photodynamic Therapy
- (2018) David Kessel PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma
- (2018) Masaki Nagane et al. PLoS One
- Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
- (2018) Luis A. Carvajal et al. Science Translational Medicine
- Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields
- (2018) Diego Martin-Sanchez et al. Cell Death & Disease
- BI2536 induces mitotic catastrophe and radiosensitization in human oral cancer cells
- (2018) Chieh-Yuan Cheng et al. Oncotarget
- Targeting BCL-2 regulated apoptosis in cancer
- (2018) Kirsteen J. Campbell et al. Open Biology
- MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin
- (2018) Katja Seipel et al. HAEMATOLOGICA
- Shikonin Inhibites Migration and Invasion of Thyroid Cancer Cells by Downregulating DNMT1
- (2018) Yue Zhang et al. MEDICAL SCIENCE MONITOR
- Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation
- (2018) Yan Su et al. Toxicology Research
- Suppressing ROS-TFE3-dependent autophagy enhances ivermectin-induced apoptosis in human melanoma cells
- (2018) Faming Deng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia
- (2018) Lu Ding et al. OncoTargets and Therapy
- High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial
- (2018) Gary J. Schiller et al. Journal of Adolescent and Young Adult Oncology
- Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
- (2018) V Urbonas et al. ANNALS OF ONCOLOGY
- Role of DDX53 in taxol-resistance of cervix cancer cells in vitro
- (2018) Su Yeon Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial
- (2018) Boris Böll et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pyroptosis versus necroptosis: similarities, differences, and crosstalk
- (2018) Daniel Frank et al. CELL DEATH AND DIFFERENTIATION
- Sorafenib: key lessons from over 10 years of experience
- (2018) Bernard Escudier et al. Expert Review of Anticancer Therapy
- Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
- (2018) Maura L Gillison et al. LANCET
- Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
- (2018) Adriana E. Tron et al. Nature Communications
- Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth
- (2018) Fiona Tan et al. Cancers
- Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis
- (2018) J. Remy et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407)
- (2017) Kohei Shitara et al. Gastric Cancer
- Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses
- (2017) Young-Su Yi IMMUNOLOGY
- Mechanisms governing inflammasome activation, assembly and pyroptosis induction
- (2017) Sannula Kesavardhana et al. INTERNATIONAL IMMUNOLOGY
- Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia
- (2017) Xiaoyan Wu et al. International Journal of Nanomedicine
- APG-1252-12A induces mitochondria-dependent apoptosis through inhibiting the antiapoptotic proteins Bcl-2/Bcl-xl in HL-60 cells
- (2017) Jing Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- ROS-modulated therapeutic approaches in cancer treatment
- (2017) Muhammad Hassan Raza et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Inflammasome activation and assembly at a glance
- (2017) Ankit Malik et al. JOURNAL OF CELL SCIENCE
- Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy
- (2017) Ana Luiza Chaves Maia et al. JOURNAL OF DRUG TARGETING
- Everolimus for Treatment of Pseudomyogenic Hemangioendothelioma
- (2017) Michio Ozeki et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia
- (2017) Ing Soo Tiong et al. LEUKEMIA & LYMPHOMA
- Everolimus: «matando 2 pájaros de un tiro» en un trasplantado hepático con sarcoma de Kaposi
- (2017) Alba Calleja-Algarra et al. MEDICINA CLINICA
- Shikonin promotes adriamycin-induced apoptosis by upregulating caspase-3 and caspase-8 in osteosarcoma
- (2017) Qing Yang et al. Molecular Medicine Reports
- Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
- (2017) Yupeng Wang et al. NATURE
- Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis
- (2017) G Chen et al. ONCOGENE
- Iron addiction: a novel therapeutic target in ovarian cancer
- (2017) D Basuli et al. ONCOGENE
- Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma
- (2017) Ashley Ghiaseddin et al. ONCOLOGIST
- ABT-737 potentiates cisplatin-induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway
- (2017) Fengtian Zhang et al. ONCOLOGY REPORTS
- Oxidative Stress in Infection and Consequent Disease
- (2017) Alexander V. Ivanov et al. Oxidative Medicine and Cellular Longevity
- Focal adhesion kinase inhibitor PF573228 and death receptor 5 agonist lexatumumab synergistically induce apoptosis in pancreatic carcinoma
- (2017) Xiangxuan Zhao et al. TUMOR BIOLOGY
- Bcl-2/Bcl-xL inhibitor ABT-737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel-induced cell death
- (2017) Shuya Kasai et al. Oncology Letters
- Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells
- (2017) Xiaoli Ma et al. Oncology Letters
- Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death
- (2017) Corey Rogers et al. Nature Communications
- Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines
- (2017) Eva Bernhart et al. Oncotarget
- Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells
- (2017) Bo Liao et al. Cancer Medicine
- CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells
- (2017) Namrata Chaudhari et al. Frontiers in Molecular Neuroscience
- Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536
- (2017) Frank Breitenbuecher et al. Oncology Research and Treatment
- Gene expression profiling and functional analysis reveals that p53 pathway-related gene expression is highly activated in cancer cells treated by cold atmospheric plasma-activated medium
- (2017) Lei Shi et al. PeerJ
- Assays to Monitor Autophagy Progression in Cell Cultures
- (2017) Idil Orhon et al. Cells
- Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
- (2016) Giuseppa Pistritto et al. Aging-US
- A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma
- (2016) T. Ciuleanu et al. ANNALS OF ONCOLOGY
- Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer
- (2016) Kui Wang et al. Autophagy
- Identification of ACSL4 as a biomarker and contributor of ferroptosis
- (2016) Hua Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- APR-246 (PRIMA-1 MET ) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines
- (2016) Christophe Deben et al. CANCER LETTERS
- The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873
- (2016) K Wang et al. CELL DEATH AND DIFFERENTIATION
- Cancer therapy in the necroptosis era
- (2016) Z Su et al. CELL DEATH AND DIFFERENTIATION
- Pyroptosis
- (2016) Lieselotte Vande Walle et al. CURRENT BIOLOGY
- Venetoclax: First Global Approval
- (2016) Emma D. Deeks DRUGS
- p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib
- (2016) Mohammad Krayem et al. EUROPEAN JOURNAL OF CANCER
- A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer
- (2016) David J. McConkey et al. EUROPEAN UROLOGY
- Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells
- (2016) M. Broecker-Preuss et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
- (2016) Steven G. DuBois et al. JOURNAL OF CLINICAL ONCOLOGY
- Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer
- (2016) Tatsuya Takayama et al. MEDICAL ONCOLOGY
- Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells
- (2016) Raffaela Silvestre Ignarro et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Mechanisms of Selective Antitumor Action of Cold Atmospheric Plasma-Derived Reactive Oxygen and Nitrogen Species
- (2016) Georg Bauer et al. Plasma Processes and Polymers
- Withaferin A Induces ROS-Mediated Paraptosis in Human Breast Cancer Cell-Lines MCF-7 and MDA-MB-231
- (2016) Kamalini Ghosh et al. PLoS One
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- Phase II study of everolimus in refractory testicular germ cell tumors
- (2016) Michal Mego et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- ROS homeostasis and metabolism: a dangerous liason in cancer cells
- (2016) E Panieri et al. Cell Death & Disease
- Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
- (2016) M. Konopleva et al. Cancer Discovery
- Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
- (2016) Åsa Fransson et al. Journal of Ovarian Research
- Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer
- (2016) Hui Guo et al. Oncotarget
- BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells
- (2016) Kan He et al. Oncotarget
- CDDO-Me reveals USP7 as a novel target in ovarian cancer cells
- (2016) Dongjun Qin et al. Oncotarget
- High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition
- (2016) Laurel T. Bate-Eya et al. Oncotarget
- Acquired resistance to venetoclax (ABT-199) in t(14;18) positive lymphoma cells
- (2016) Juraj Bodo et al. Oncotarget
- Complete response to weekly carboplatin–docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer
- (2015) Haralabos Koussis et al. AMERICAN JOURNAL OF OTOLARYNGOLOGY
- A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer
- (2015) Baris Turkbey et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma
- (2015) Yan Zhao et al. BIOMATERIALS
- BI2536 – A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells
- (2015) B.N. Prashanth Kumar et al. BIOMEDICINE & PHARMACOTHERAPY
- A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial
- (2015) Ranjana H. Advani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
- (2015) Isaac S. Harris et al. CANCER CELL
- Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis
- (2015) Ciric To et al. CARCINOGENESIS
- Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses
- (2015) Le Jiang et al. CELL CYCLE
- The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma
- (2015) J. L. Pokorny et al. CLINICAL CANCER RESEARCH
- The utility of chloroquine in cancer therapy
- (2015) Yuan Zhang et al. CURRENT MEDICAL RESEARCH AND OPINION
- APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma
- (2015) David S H Liu et al. GUT
- A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA)
- (2015) Fiona Simpkins et al. GYNECOLOGIC ONCOLOGY
- Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies
- (2015) Joleen M. Hubbard et al. INVESTIGATIONAL NEW DRUGS
- ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
- (2015) Shundong Cang et al. Journal of Hematology & Oncology
- Synthesis of CDDO–Amino Acid–Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer
- (2015) Yong Ai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cambogin Induces Caspase-Independent Apoptosis through the ROS/JNK Pathway and Epigenetic Regulation in Breast Cancer Cells
- (2015) K. Shen et al. MOLECULAR CANCER THERAPEUTICS
- Ferroptosis as a p53-mediated activity during tumour suppression
- (2015) Le Jiang et al. NATURE
- L744,832 and Everolimus Induce Cytotoxic and Cytostatic Effects in Non-Hodgkin Lymphoma Cells
- (2015) José Mendes et al. PATHOLOGY & ONCOLOGY RESEARCH
- Knockdown of BAG3 sensitizes bladder cancer cells to treatment with the BH3 mimetic ABT-737
- (2015) Jens Mani et al. WORLD JOURNAL OF UROLOGY
- Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells
- (2015) HAIYANG ZHANG et al. Experimental and Therapeutic Medicine
- PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms
- (2015) Xiao-Lan Li et al. Oncotarget
- RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel
- (2015) Jing Guo et al. Oncotarget
- Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer
- (2015) Ji-Ae Shin et al. Oncotarget
- Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells
- (2015) Joyce P.Y. Mak et al. Oncotarget
- Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death
- (2015) Dobrin Draganov et al. Scientific Reports
- Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
- (2015) Tae Won Kwak et al. JOURNAL OF NANOBIOTECHNOLOGY
- Brain-Targeted Delivery of Docetaxel by Glutathione-Coated Nanoparticles for Brain Cancer
- (2014) Aditya Grover et al. AAPS PHARMSCITECH
- Inhibition of Nemo-like Kinase Increases Taxol Sensitivity in Laryngeal Cancer
- (2014) Ji-Rui Dong et al. Asian Pacific Journal of Cancer Prevention
- A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
- (2014) Dong-Wan Kim et al. BMC CANCER
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- Autosis and autophagic cell death: the dark side of autophagy
- (2014) Y Liu et al. CELL DEATH AND DIFFERENTIATION
- Old, new and emerging functions of caspases
- (2014) S Shalini et al. CELL DEATH AND DIFFERENTIATION
- The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
- (2014) A. Melotti et al. EMBO Molecular Medicine
- Enhanced primary tumor delineation in pancreatic adenocarcinoma using ultrasmall super paramagnetic iron oxide nanoparticle-ferumoxytol: an initial experience with histopathologic correlation
- (2014) Sandeep Hedgire et al. International Journal of Nanomedicine
- Beclin-1-p53 interaction is crucial for cell fate determination in embryonal carcinoma cells
- (2014) Rakshamani Tripathi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
- (2014) Wenxiu Qi et al. Journal of Hematology & Oncology
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal
- (2014) S. Salzano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor Dynamics in Response to Antiangiogenic Therapy with Oral Metronomic Topotecan and Pazopanib in Neuroblastoma Xenografts
- (2014) Sushil Kumar et al. Translational Oncology
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- A case of metastatic adamantinoma responding to treatment with pazopanib
- (2013) Yasmin Cohen et al. ACTA ONCOLOGICA
- Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma
- (2013) Aleksandr Lazaryan et al. AMERICAN JOURNAL OF HEMATOLOGY
- A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib
- (2013) K. N. Ganjoo et al. ANNALS OF ONCOLOGY
- Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
- (2013) Mercè Juliachs et al. BMC CANCER
- Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma
- (2013) D N T Aryee et al. BRITISH JOURNAL OF CANCER
- Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
- (2013) H K Ahn et al. BRITISH JOURNAL OF CANCER
- A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
- (2013) T Meyer et al. BRITISH JOURNAL OF CANCER
- The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells
- (2013) Shuyu Li et al. Cancer Cell International
- Necrosis-dependent and independent signaling of the RIP kinases in inflammation
- (2013) Kenta Moriwaki et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Role of oxidative stress in infectious diseases. A review
- (2013) Miroslav Pohanka FOLIA MICROBIOLOGICA
- p53 Mediates Autophagy and Cell Death by a Mechanism Contingent On Bnip3
- (2013) Erika Yan Wang et al. HYPERTENSION
- An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer
- (2013) Joanne Brady et al. INVESTIGATIONAL NEW DRUGS
- Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer
- (2013) Valentina De Falco et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New Prospects for Vinblastine Analogues as Anticancer Agents
- (2013) Romano Silvestri JOURNAL OF MEDICINAL CHEMISTRY
- A Prospective Phase II Trial of Induction Chemotherapy with Docetaxel/Cisplatin for Masaoka Stage III/IV thymic Epithelial Tumors
- (2013) Silvia Park et al. Journal of Thoracic Oncology
- Determination of apoptotic and necrotic cell death in vitro and in vivo
- (2013) Tom Vanden Berghe et al. METHODS
- Taxol: Efficacy Against Oral Squamous Cell Carcinoma
- (2013) Kaitlyn Ledwitch et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa
- (2013) Manujendra N. Saha et al. MOLECULAR CANCER THERAPEUTICS
- Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
- (2013) Laura Bergadà et al. Molecular Oncology
- Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1
- (2013) MINGQIANG REN et al. ONCOLOGY REPORTS
- Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas
- (2013) Jenny M. Kreahling et al. PLoS One
- A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder
- (2013) Petros D. Grivas et al. UROLOGY
- Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells
- (2012) Cornel J Phillip et al. BMC CANCER
- First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial
- (2012) Ó Arrieta et al. BRITISH JOURNAL OF CANCER
- Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumoursin vivo
- (2012) S Ackler et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
- (2012) Liming Sun et al. CELL
- p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
- (2012) Angelina V. Vaseva et al. CELL
- Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours
- (2012) A. Frost et al. Current Oncology
- Clinical trial of weekly paclitaxel chemotherapy for papillary thyroid carcinoma with squamous cell carcinoma component
- (2012) Yasuhiro Ito et al. ENDOCRINE JOURNAL
- A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261
- (2012) Keith C. Bible et al. GYNECOLOGIC ONCOLOGY
- Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells
- (2012) Vasileios A. Stamelos et al. GYNECOLOGIC ONCOLOGY
- Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells
- (2012) SU-JIN LEE et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The emerging role of reactive oxygen and nitrogen species in redox biology and some implications for plasma applications to medicine and biology
- (2012) David B Graves JOURNAL OF PHYSICS D-APPLIED PHYSICS
- Navitoclax (ABT-263) Reduces Bcl-xL-Mediated Chemoresistance in Ovarian Cancer Models
- (2012) M. Wong et al. MOLECULAR CANCER THERAPEUTICS
- Insight into the Cooperation of P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) at the Blood–Brain Barrier: A Case Study Examining Sorafenib Efflux Clearance
- (2012) Sagar Agarwal et al. MOLECULAR PHARMACEUTICS
- Preclinical Pharmacokinetic and Pharmacodynamic Evaluation of Novel Anticancer Agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for Brain Tumor Chemotherapy
- (2012) Silpa Nuthalapati et al. PHARMACEUTICAL RESEARCH
- ABT-737 is highly effective against molecular subgroups of multiple myeloma
- (2011) L. Bodet et al. BLOOD
- Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial
- (2011) Mary Cianfrocca et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phosphorylation of survivin at threonine 34 inhibits its mitotic function and enhances its cytoprotective activity
- (2011) Rachel M.A. Barrett et al. CELL CYCLE
- DRAM: A phylogenetically ancient regulator of autophagy
- (2011) Alfredo Criollo et al. CELL CYCLE
- The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis
- (2011) Jason L. Townson et al. CLINICAL & EXPERIMENTAL METASTASIS
- MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
- (2011) N. V. Rajeshkumar et al. CLINICAL CANCER RESEARCH
- Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma
- (2011) H. Fang et al. CLINICAL CANCER RESEARCH
- Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer
- (2011) Lisa M. Landrum et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
- (2011) Daniel T. T. Chua et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling
- (2011) Valentina Gandin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Clinical Trial of Vinblastine in Dogs with Transitional Cell Carcinoma of the Urinary Bladder
- (2011) E.J. Arnold et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines
- (2011) Jane Levesley et al. NEURO-ONCOLOGY
- The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells
- (2011) Nathalie Allaman-Pillet et al. OPHTHALMIC GENETICS
- Reactive Oxygen Species Is Essential for Cycloheximide to Sensitize Lexatumumab-Induced Apoptosis in Hepatocellular Carcinoma Cells
- (2011) Xiangxuan Zhao et al. PLoS One
- Mitotic Catastrophe Occurs in the Absence of Apoptosis in p53-Null Cells with a Defective G1 Checkpoint
- (2011) Michalis Fragkos et al. PLoS One
- Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer
- (2011) Sofie Claerhout et al. PLoS One
- Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival
- (2011) Lucie Oberic et al. Radiation Oncology
- Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer
- (2010) P. W. Gout et al. Current Oncology
- Autophagy regulation by p53
- (2010) Maria Chiara Maiuri et al. CURRENT OPINION IN CELL BIOLOGY
- Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2010) Leo Mascarenhas et al. JOURNAL OF CLINICAL ONCOLOGY
- Autophagy: cellular and molecular mechanisms
- (2010) Danielle Glick et al. JOURNAL OF PATHOLOGY
- Redox Regulation in Cancer: A Double-edged Sword with Therapeutic Potential
- (2010) Asha Acharya et al. Oxidative Medicine and Cellular Longevity
- Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia
- (2010) Yoshihisa Nagatoshi et al. PEDIATRIC BLOOD & CANCER
- An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe
- (2010) S Rello-Varona et al. Cell Death & Disease
- PUMA- and Bax-induced autophagy contributes to apoptosis
- (2009) K S Yee et al. CELL DEATH AND DIFFERENTIATION
- Phase II Trial of Carboplatin and Paclitaxel in Papillary Renal Cell Carcinoma
- (2009) Kathryn A. Bylow et al. Clinical Genitourinary Cancer
- ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy
- (2009) Ian G. Ganley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Taxol induces paraptosis independent of both protein synthesis and MAPK pathway
- (2009) Qingrui Sun et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib
- (2009) T. A. Luster et al. MOLECULAR CANCER THERAPEUTICS
- Coupling of Endoplasmic Reticulum Stress to CDDO-Me-Induced Up-regulation of Death Receptor 5 via a CHOP-Dependent Mechanism Involving JNK Activation
- (2008) W. Zou et al. CANCER RESEARCH
- Necroptosis: A Specialized Pathway of Programmed Necrosis
- (2008) Lorenzo Galluzzi et al. CELL
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
- (2008) Andrei V. Budanov et al. CELL
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
- (2008) G Kroemer et al. CELL DEATH AND DIFFERENTIATION
- Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells
- (2008) Wan Seok Yang et al. CHEMISTRY & BIOLOGY
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Targeting the extrinsic apoptosis pathway in cancer
- (2008) Avi Ashkenazi CYTOKINE & GROWTH FACTOR REVIEWS
- Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer
- (2008) William P. Tew et al. INVESTIGATIONAL NEW DRUGS
- Inflammation and oxidative stress in vertebrate host-parasite systems
- (2008) G. Sorci et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by shikonin was partly through the inactivation of NF-κB pathway
- (2007) Min Ruan et al. PHYTOTHERAPY RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now